Gastrointestinal and hepatic manifestations of mitochondrial disorders

Journal of Inherited Metabolic Disease

Volumn 36, Issue 4, 2013, Pages 659-673

  Rahman, Shamima ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACYLCARNITINE; ADENOVIRUS VECTOR; CYTOCHROME C OXIDASE; DEOXYURIDINE; GLUTAMATE TRANSFER RNA LIGASE; LENTIVIRUS VECTOR; MEMBRANE LIPID; METHYLMALONIC ACID; METRONIDAZOLE; MITOCHONDRIAL DNA; THYMIDINE PHOSPHORYLASE; TRANSFER RNA;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; BCS1L GENE; BIOCHEMISTRY; CLINICAL EXAMINATION; CONFERENCE PAPER; DGUOK GENE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EARS2 GENE; ETHE1 GENE; ETHYLMALONIC ENCEPHALOPATHY; GASTROINTESTINAL DISEASE; GENE; GENE MUTATION; GENETIC HETEROGENEITY; GFM1 GENE; HUMAN; INTESTINE VILLUS ATROPHY; LEIGH DISEASE; LIVER DISEASE; LIVER TRANSPLANTATION; MELAS SYNDROME; MITOCHONDRIAL DNA DEPLETION SYNDROME; MITOCHONDRIAL DNA DISORDER; MITOCHONDRIAL ENCEPHALOPATHY; MNGIE SYNDROME; MPV17 GENE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PEARSON SYNDROME; PEO1 GENE; POLG GENE; PROTEIN EXPRESSION; PUS1 GENE; SUCLG1 GENE; SURF1 GENE; TRMU GENE; VIRAL GENE DELIVERY SYSTEM; YARS2 GENE;

ANIMALS; BRAIN DISEASES, METABOLIC, INBORN; DNA, MITOCHONDRIAL; GASTROINTESTINAL DISEASES; HUMANS; LIVER DISEASES; MITOCHONDRIAL DISEASES; MITOCHONDRIAL ENCEPHALOMYOPATHIES; PURPURA;

EID: 84880227427     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-013-9614-2     Document Type: Conference Paper

References (106)

1. Antonicka H, Sasarman F, Kennaway NG, Shoubridge EA (2006) The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum Mol Genet 15:1835-1846
2. Arnaudo E, Dalakas M, Shanske S, Moraes CT, Dimauro S, Schon EA (1991) Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy. Lancet 337:508-510
3. Bicknese AR, May W, Hickey WF, Dodson WE (1992) Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity. Ann Neurol 32:767-775
4. Bitner-Glindzicz M, Pembrey M, Duncan A et al (2009) Prevalence of mitochondrial 1555A->G mutation in European children. N Engl J Med 360:640-642
5. Chang TM, Chi CS, Tsai CR, Lee HF, Li MC (2004) Paralytic ileus in MELAS with phenotypic features of MNGIE. Pediatr Neurol 31:374-377
6. Chrzanowska-Lightowlers ZM, Horvath R, Lightowlers RN (2011) 175th ENMC international workshop: mitochondrial protein synthesis in health and disease, 25-27th June 2010, Naarden, The Netherlands. Neuromuscul Disord 21:142-147
7. Coenen MJ, Antonicka H, Ugalde C et al (2004) Mutant mitochondrial elongation factor G1 and combined oxidative phosphorylation deficiency. N Engl J Med 351:2080-2086
8. Cohen BH, Chinnery PF, Copeland WC et al (2010) POLG-Related Disorders. 2010 Mar 16 [Updated 2012 Oct 11]. In: Pagon RA, Bird TD, Dolan CR (eds) GeneReviews™ [internet]. University of Washington, Seattle, 1993-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK26471/
9. Cormier-Daire V, Bonnefont JP, Rustin P et al (1994) Mitochondrial DNA rearrangements with onset as chronic diarrhea with villous atrophy. J Pediatr 124:63-70
10. Cormier-Daire V, Chretien D, Rustin P et al (1997) Neonatal and delayed-onset liver involvement in disorders of oxidative phosphorylation. J Pediatr 130:817-822
11. Darin N, Oldfors A, Moslemi AR, Holme E, Tulinius M (2001) The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological, biochemical, and DNA anbormalities. Ann Neurol 49:377-383
12. de Lonlay P, Valnot I, Barrientos A et al (2001) A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 29:57-60
13. Debray FG, Morin C, Janvier A et al (2011) LRPPRC mutations cause a phenotypically distinct form of Leigh syndrome with cytochrome c oxidase deficiency. J Med Genet 48(3):183-9
14. Delarue A, Paut O, Guys JM et al (2000) Inappropriate liver transplantation in a child with Alpers-Huttenlocher syndrome misdiagnosed as valproate-induced acute liver failure. Pediatr Transplant 4:67-71
15. Di Meo I, Auricchio A, Lamperti C, Burlina A, Viscomi C, Zeviani M (2012) Effective AAV-mediated gene therapy in a mouse model of ethylmalonic encephalopathy. EMBO Mol Med 4:1008-1014
16. Dimmock DP, Dunn JK, Feigenbaum A et al (2008a) Abnormal neurological features predict poor survival and should preclude liver transplantation in patients with deoxyguanosine kinase deficiency. Liver Transpl 14:1480-1485
17. Dimmock DP, Zhang Q, Dionisi-Vici C et al (2008b) Clinical and molecular features of mitochondrial DNA depletion due to mutations in deoxyguanosine kinase. Hum Mutat 29:330-331
18. Dubern B, Broue P, Dubuisson C et al (2001) Orthotopic liver transplantation for mitochondrial respiratory chain disorders: a study of 5 children. Transplantation 71:633-637
19. El-Hattab AW, Li FY, Schmitt E, Zhang S, Craigen WJ, Wong LJ (2010) MPV17-associated hepatocerebral mitochondrial DNA depletion syndrome: new patients and novel mutations. Mol Genet Metab 99:300-308
20. Elo JM, Yadavalli SS, Euro L et al (2012) Mitochondrial phenylalanyl-tRNA synthetase mutations underlie fatal infantile Alpers encephalopathy. Hum Mol Genet 21:4521-4529
21. Fassone E, Rahman S (2012) Complex I deficiency: clinical features, biochemistry and molecular genetics. J Med Genet 49:578-590
22. Filosto M, Scarpelli M, Tonin P et al (2012) Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy. J Neurol 259:2699-2706
23. Fleming MD (2011) Congenital sideroblastic anemias: iron and heme lost in mitochondrial translation. Hematology Am Soc Hematol Educ Program 2011:525-531
24. Freisinger P, Futterer N, Lankes E et al (2006) Hepatocerebral mitochondrial DNA depletion syndrome caused by deoxyguanosine kinase (DGUOK) mutations. Arch Neurol 63:1129-1134
25. Galmiche L, Serre V, Beinat M et al (2012) Toward genotype phenotype correlations in GFM1 mutations. Mitochondrion 12:242-247
26. Garone C, Tadesse S, Hirano M (2011) Clinical and genetic spectrum of mitochondrial neurogastrointestinal encephalomyopathy. Brain 134:3326-3332
27. Giordano C, Viscomi C, Orlandi M et al (2012) Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy. J Inherit Metab Dis 35:451-458
28. Goldstein A, Wolfe LA (2013) The elusive magic pill: finding effective therapies for mitochondrial disorders. Neurotherapeutics 10(2):320-8
29. Goncalves I, Hermans D, Chretien D et al (1995) Mitochondrial respiratory chain defect: a new etiology for neonatal cholestasis and early liver insufficiency. J Hepatol 23:290-294
30. Hakonen AH, Goffart S, Marjavaara S et al (2008) Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion. Hum Mol Genet 17:3822-3835
31. Halter J, Schupbach WM, Casali C et al (2011) Allogeneic hematopoietic SCT as treatment option for patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a consensus conference proposal for a standardized approach. Bone Marrow Transplant 46:330-337
32. Harding BN (1990) Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol 5:273-287
33. Hinson JT, Fantin VR, Schonberger J et al (2007) Missense mutations in the BCS1L gene as a cause of the Bjornstad syndrome. N Engl J Med 356:809
34. Hirano M, Ricci E, Koenigsberger MR et al (1992) Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord 2:125-135
35. Hirano M, Nishigaki Y, Marti R (2004) Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes. Neurologist 10:8-17
36. Hirano M, Marti R, Casali C et al (2006) Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 67:1458-1460
37. Isohanni P, Hakonen AH, Euro L et al (2011) POLG1 manifestations in childhood. Neurology 76:811-815
38. Iwama I, Baba Y, Kagimoto S et al (2011) Case report of a successful liver transplantation for acute liver failure due to mitochondrial respiratory chain complex III deficiency. Transplant Proc 43:4025-4028
39. Kaji S, Murayama K, Nagata I et al (2009) Fluctuating liver functions in siblings with MPV17 mutations and possible improvement associated with dietary and pharmaceutical treatments targeting respiratory chain complex II. Mol Genet Metab 97:292-296
40. Karadimas CL, Vu TH, Holve SA et al (2006) Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet 79:544-548
41. Karkucinska-Wieckowska A, Lebiedzinska M, Jurkiewicz E et al (2011) Increased reactive oxygen species (ROS) production and low catalase level in fibroblasts of a girl with MEGDEL association (Leigh syndrome, deafness, 3-methylglutaconic aciduria). Folia Neuropathol 49:56-63
42. Kayihan N, Nennesmo I, Ericzon BG, Nemeth A (2000) Fatal deterioration of neurological disease after orthotopic liver transplantation for valproic acid-induced liver damage. Pediatr Transplant 4:211-214
43. Koene S, Rodenburg RJ, van der Knaap MS et al (2012) Natural disease course and genotype-phenotype correlations in complex I deficiency caused by nuclear gene defects: what we learned from 130 cases. J Inherit Metab Dis 35:737-747
44. Lee WS, Sokol RJ (2007) Mitochondrial hepatopathies: advances in genetics and pathogenesis. Hepatology 45:1555-1565
45. Mancuso M, Ferraris S, Pancrudo J et al (2005) New DGK gene mutations in the hepatocerebral form of mitochondrial DNA depletion syndrome. Arch Neurol 62:745-747
46. Mandel H, Szargel R, Labay V et al (2001) The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 29:337-341
47. Maniura-Weber K, Taylor RW, Johnson MA et al (2004) A novel point mutation in the mitochondrial tRNA(Trp) gene produces a neurogastrointestinal syndrome. Eur J Hum Genet 12:509-512
48. McShane MA, Hammans SR, Sweeney M et al (1991) Pearson syndrome and mitochondrial encephalomyopathy in a patient with a deletion of mtDNA. Am J Hum Genet 48:39-42
49. Moran NF, Bain MD, Muqit MM, Bax BE (2008) Carrier erythrocyte entrapped thymidine phosphorylase therapy for MNGIE. Neurology 71:686-688
50. Morris EM, Rector RS, Thyfault JP, Ibdah JA (2011) Mitochondria and redox signaling in steatohepatitis. Antioxid Redox Signal 15:485-504
51. Mousson de Camaret B, Taanman JW, Padet S et al (2007) Kinetic properties of mutant deoxyguanosine kinase in a case of reversible hepatic mtDNA depletion. Biochem J 402:377-385
52. Mudd SH, Wagner C, Luka Z et al (2012) Two patients with hepatic mtDNA depletion syndromes and marked elevations of S-adenosylmethionine and methionine. Mol Genet Metab 105:228-236
53. Navarro-Sastre A, Martin-Hernandez E, Campos Y et al (2008) Lethal hepatopathy and leukodystrophy caused by a novel mutation in MPV17 gene: description of an alternative MPV17 spliced form. Mol Genet Metab 94:234-239
54. Naviaux RK, Nguyen KV (2004) POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 55:706-712
55. Nesbitt V, Pitceathly RD, Turnbull DM et al (2013) The UK MRC Mitochondrial disease patient cohort study: clinical phenotypes associated with the m.3243A>G mutation-implications for diagnosis and management. J Neurol Neurosurg Psychiatry Jan 25 [Epub ahead of print]
56. Nobre S, Grazina M, Silva F, Pinto C, Goncalves I, Diogo L (2012) Neonatal liver failure due to deoxyguanosine kinase deficiency. BMJ Case Rep 2012 doi: 10.1136/bcr.12.2011.5317
57. Okamura K, Santa T, Nagae K, Omae T (1976) Congenital oculoskeletal myopathy with abnormal muscle and liver mitochondria. J Neurol Sci 27:79-91
58. Ostergaard E, Christensen E, Kristensen E et al (2007) Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet 81:383-387
59. Parini R, Furlan F, Notarangelo L et al (2009) Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients. J Hepatol 50:215-221
60. Pearson HA, Lobel JS, Kocoshis SA et al (1979) A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunction. J Pediatr 95:976-984
61. Pitceathly RD, Rahman S, Hanna MG (2012) Single deletions in mitochondrial DNA-molecular mechanisms and disease phenotypes in clinical practice. Neuromuscul Disord 22:577-586
62. Rahman S (2012) Mitochondrial disease and epilepsy. Dev Med Child Neurol 54:397-406
63. Rahman S, Hanna MG (2009) Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases. J Neurol Neurosurg Psychiatry 80:943-953
64. Rahman S, Poulton J (2009) Diagnosis of mitochondrial DNA depletion syndromes. Arch Dis Child 94:3-5
65. Rahman S, Ecob R, Costello H et al (2012) Hearing in 44-45 year olds with m.1555A>G, a genetic mutation predisposing to aminoglycoside-induced deafness: a population based cohort study. BMJ Open 2:e000411
66. Rake JP, Van Spronsen FJ, Visser G et al (2000) End-stage liver disease as the only consequence of a mitochondrial respiratory chain deficiency: no contra-indication for liver transplantation. Eur J Pediatr 159:523-526
67. Rivera H, Merinero B, Martinez-Pardo M et al (2010) Marked mitochondrial DNA depletion associated with a novel SUCLG1 gene mutation resulting in lethal neonatal acidosis, multi-organ failure, and interrupted aortic arch. Mitochondrion 10:362-368
68. Ronchi D, Garone C, Bordoni A et al (2012) Next-generation sequencing reveals DGUOK mutations in adult patients with mitochondrial DNA multiple deletions. Brain 135(Pt 11):3404-15
69. Rotig A, Colonna M, Bonnefont JP et al (1989) Mitochondrial DNA deletion in Pearson's marrow/pancreas syndrome. Lancet 1:902-903
70. Rotig A, Bourgeron T, Chretien D, Rustin P, Munnich A (1995) Spectrum of mitochondrial DNA rearrangements in the Pearson marrow-pancreas syndrome. Hum Mol Genet 4:1327-1330
71. Sakamoto O, Ohura T, Murayama K et al (2011) Neonatal lactic acidosis with methylmalonic aciduria due to novel mutations in the SUCLG1 gene. Pediatr Int 53:921-925
72. Salviati L, Sacconi S, Mancuso M et al (2002) Mitochondrial DNA depletion and dGK gene mutations. Ann Neurol 52:311-317
73. Saneto RP, Lee IC, Koenig MK et al (2010) POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders. Seizure 19:140-146
74. Sarzi E, Goffart S, Serre V et al (2007) Twinkle helicase (PEO1) gene mutation causes mitochondrial DNA depletion. Ann Neurol 62:579-587
75. Schapira AH (2012) Mitochondrial diseases. Lancet 379:1825-1834
76. Schara U, Von Kleist-Retzow JC, Lainka E et al (2011) Acute liver failure with subsequent cirrhosis as the primary manifestation of TRMU mutations. J Inherit Metab Dis 34:197-201
77. Shaibani A, Shchelochkov OA, Zhang S et al (2009) Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol 66:1028-1032
78. Slama A, Giurgea I, Debrey D et al (2005) Deoxyguanosine kinase mutations and combined deficiencies of the mitochondrial respiratory chain in patients with hepatic involvement. Mol Genet Metab 86:462-465
79. Spiegler J, Stefanova I, Hellenbroich Y, Sperner J (2011) Bowel obstruction in patients with Alpers-Huttenlocher syndrome. Neuropediatrics 42:194-196
80. Spinazzola A, Viscomi C, Fernandez-Vizarra E et al (2006) MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 38:570-575
81. Sproule DM, Kaufmann P (2008) Mitochondrial encephalopathy, lactic acidosis, and strokelike episodes: basic concepts, clinical phenotype, and therapeutic management of MELAS syndrome. Ann N Y Acad Sci 1142:133-158
82. Steenweg ME, Ghezzi D, Haack T et al (2012) Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations. Brain 135:1387-1394
83. Stiburek L, Vesela K, Hansikova H, Hulkova H, Zeman J (2009) Loss of function of Sco1 and its interaction with cytochrome c oxidase. Am J Physiol Cell Physiol 296:C1218-C1226
84. Tadiboyina VT, Rupar A, Atkison P et al (2005) Novel mutation in DGUOK in hepatocerebral mitochondrial DNA depletion syndrome associated with cystathioninuria. Am J Med Genet A 135:289-291
85. Talim B, Pyle A, Griffin H et al (2013) Multisystem fatal infantile disease caused by a novel homozygous EARS2 mutation. Brain 136:e228
86. Thomson M, McKiernan P, Buckels J, Mayer D, Kelly D (1998) Generalised mitochondrial cytopathy is an absolute contraindication to orthotopic liver transplant in childhood. J Pediatr Gastroenterol Nutr 26:478-481
87. Thorburn DR (2004) Mitochondrial disorders: prevalence, myths and advances. J Inherit Metab Dis 27:349-362
88. Thorburn DR, Rahman S (2003) Mitochondrial DNA-associated leigh syndrome and NARP. 2003 Oct 30 [Updated 2011 May 3]. In: Pagon RA, Bird TD, Dolan CR et al (eds) GeneReviews™ [Internet]. Seattle (WA): University of Washington, Seattle; 1993-. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1173/
89. Tiranti V, Zeviani M (2013) Altered sulfide (H2S) metabolism in ethylmalonic encephalopathy. Cold Spring Harb Perspect Biol 5(1):a011437
90. Tiranti V, D'Adamo P, Briem E et al (2004) Ethylmalonic encephalopathy is caused by mutations in ETHE1, a gene encoding a mitochondrial matrix protein. Am J Hum Genet 74:239-252
91. Tiranti V, Viscomi C, Hildebrandt T et al (2009) Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. Nat Med 15:200-205
92. Torres-Torronteras J, Gomez A, Eixarch H et al (2011) Hematopoietic gene therapy restores thymidine phosphorylase activity in a cell culture and a murine model of MNGIE. Gene Ther 18:795-806
93. Tzoulis C, Engelsen BA, Telstad W et al (2006) The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain 129:1685-1692
94. Vafai SB, Mootha VK (2012) Mitochondrial disorders as windows into an ancient organelle. Nature 491:374-383
95. Valayannopoulos V, Haudry C, Serre V et al (2010) New SUCLG1 patients expanding the phenotypic spectrum of this rare cause of mild methylmalonic aciduria. Mitochondrion 10:335-341
96. Valnot I, Osmond S, Gigarel N et al (2000) Mutations of the SCO1 gene in mitochondrial cytochrome c oxidase deficiency with neonatal-onset hepatic failure and encephalopathy. Am J Hum Genet 67:1104-1109
97. Van Goethem G, Schwartz M, Lofgren A, Dermaut B, Van BC, Vissing J (2003) Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy. Eur J Hum Genet 11:547-549
98. Van Hove JL, Saenz MS, Thomas JA et al (2010) Succinyl-CoA ligase deficiency: a mitochondrial hepatoencephalomyopathy. Pediatr Res 68:159-164
99. Verma A, Piccoli DA, Bonilla E, Berry GT, Dimauro S, Moraes CT (1997) A novel mitochondrial G8313A mutation associated with prominent initial gastrointestinal symptoms and progressive encephaloneuropathy. Pediatr Res 42:448-454
100. Visapaa I, Fellman V, Vesa J et al (2002) GRACILE syndrome, a lethal metabolic disorder with iron overload, is caused by a point mutation in BCS1L. Am J Hum Genet 71:863-876
101. Viscomi C, Burlina AB, Dweikat I et al (2010) Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. Nat Med 16:869-871
102. Wolf NI, Rahman S, Schmitt B et al (2009) Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI features. Epilepsia 50:1596-1607
103. Wong LJ, Brunetti-Pierri N, Zhang Q et al (2007) Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology 46:1218-1227
104. Wong LJ, Naviaux RK, Brunetti-Pierri N et al (2008) Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat 29:E150-E172
105. Wortmann SB, Vaz FM, Gardeitchik T et al (2012) Mutations in the phospholipid remodeling gene SERAC1 impair mitochondrial function and intracellular cholesterol trafficking and cause dystonia and deafness. Nat Genet 44:797-802
106. Zeharia A, Shaag A, Pappo O et al (2009) Acute infantile liver failure due to mutations in the TRMU gene. Am J Hum Genet 85:401-407